Navigation Links
Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, S
Date:5/8/2013

NEW YORK, May 8, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, Size, S
http://www.reportlinker.com/p01172048/Peripheral-Vascular-Devices-Market-Peripheral-Vascular-Stents-PTA-Balloon-Catheters-Guidewires-IVC-Filters-Atherectomy-Chronic-Total-Occlusion-Embolic-Protection-Devices-Synthetic-Surgical-Grafts-Aortic-Stents---Global-Industry-Analysis-Size-S.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory

The research report on the peripheral vascular devices market provides detailed analysis of the global market and helps in understanding the driving forces for the growth of these devices. The report also provides analysis of major segments such as peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices and inferior vena cava filters. Market size estimates and forecasts for the period 2010 to 2018 has been given for each segment and its sub-segment, in terms of USD million, calculating growth rates from 2012 to 2018, considering 2011 as the base year for calculations.

The market has been segmented geographically into four regions namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). Market size and forecast is provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the peripheral vascular devices market and future opportunities are provided in the report.

Competitive landscape for each of the product types is highlighted and market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2011 are provided, and recommendations to accentuate market shares and ensure sustainability are provided in this report. Key market player profiles in this report include Abbott Laboratories, Boston Scientific Corporation, C.R.Bard Inc., Cordis Corporation, Medtronic and others.
?
The global peripheral vascular devices market is segmented into the following categories:

Peripheral Vascular Devices Market, by Segment
Peripheral vascular stents
Peripheral transluminal angioplasty balloon catheters
PTA guidewires
Atherectomy devices
Chronic total occlusion devices
Aortic stents
Synthetic surgical grafts
Embolic protection devices
Inferior vena cava filters

Peripheral Vascular Devices Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Table of Contents

Chapter 1 Executive Summary
1.1 Market Snapshot: Global Peripheral Vascular Devices Market (2011 & 2018)
1.2 Global Peripheral Vascular Devices Market, by Product Types, 2011 (USD Million)

Chapter 2 Preface
2.1 Report description
2.2 Market Segmentation
2.3 Research Methodology

Chapter 3 Industry Analysis
3.1 Introduction
3.2 Market Drivers
3.2.1 Rapidly increasing aging population
3.2.2 Rising incidence rate of PVD
3.2.3 Increasing demand for minimally invasive endovascular procedures
3.2.4 Increase in specialists treating PVD
3.2.5 Impact Analysis of Market Drivers
3.3 Market Restraints
3.3.1 Infections from peripheral vascular implantations
3.3.2 Strict approval process from government bodies
3.3.3 Impact Analysis of Market Restraints
3.4 Market Opportunities
3.4.1 Big opportunity in emerging economies with high unmet needs
3.5 Porter's Five Forces Analysis
3.5.1 Bargaining power of buyers
3.5.2 Bargaining power of suppliers
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis

Chapter 4 Global Peripheral Vascular Devices Market, by Segments
4.1 Overview
4.1.1 Global Peripheral Vascular Devices Market, by Product Types, 2010 – 2018 (USD Million)
4.2 Peripheral Vascular Stents
4.2.1 Global Peripheral Vascular Stents Market, by Segments, 2010 – 2018 (USD Million)
4.3 Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
4.3.1 Global Peripheral Transluminal Angioplasty Balloon Catheters Market, 2010 – 2018 (USD Million)
4.4 PTA Guidewires
4.4.1 Global PTA Guidewires Market, 2010 – 2018 (USD Million)
4.5 Atherectomy Devices
4.5.1 Global Atherectomy Devices Market, by Segments, 2010 – 2018 (USD Million)
4.6 Chronic Total Occlusion (CTO) Devices
4.6.1 Global Chronic Total Occlusion Devices Market, 2010 – 2018 (USD Million)
4.7 Aortic Stents
4.7.1 Global Aortic Stents Market, 2010 – 2018 (USD Million)
4.8 Synthetic Surgical Grafts
4.8.1 Global Synthetic Surgical Grafts Market, 2010 – 2018 (USD Million)
4.9 Embolic Protection Devices
4.9.1 Global Embolic Protection Devices Market, by Segments, 2010 – 2018 (USD Million)
4.10 Inferior Vena Cava Filters
4.10.1 Global Inferior Vena Cava Filters Market, by Segments, 2010 – 2018 (USD Million)

Chapter 5 Global Peripheral Vascular Devices Market, by Geography
5.1 Overview
5.1.1 Global Peripheral Vascular Devices Market, by Geography, 2010 – 2018 (USD Million)
5.2 Comparative Analysis: Peripheral Vascular Devices Market, by Geography, 2011 & 2018 (Value %)
5.3 North America
5.3.1 North America Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
5.3.1.1 Peripheral vascular stents
5.3.1.2 Peripheral transluminal angioplasty balloon catheters
5.3.1.3 PTA guidewires
5.3.1.4 Atherectomy devices
5.3.1.5 Chronic total occlusion devices
5.3.1.6 Aortic stents
5.3.1.7 Synthetic surgical grafts
5.3.1.8 Embolic protection devices
5.3.1.9 Inferior vena cava filters
5.4 Europe
5.4.1 Europe Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
5.4.1.1 Peripheral vascular stents
5.4.1.2 Peripheral transluminal angioplasty balloon catheters
5.4.1.3 PTA guidewires
5.4.1.4 Atherectomy devices
5.4.1.5 Chronic total occlusion devices
5.4.1.6 Aortic stents
5.4.1.7 Synthetic surgical grafts
5.4.1.8 Embolic protection devices
5.4.1.9 Inferior vena cava filters
5.5 Asia-Pacific
5.5.1 Asia-Pacific Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
5.5.1.1 Peripheral vascular stents
5.5.1.2 Peripheral transluminal angioplasty balloon catheters
5.5.1.3 PTA guidewires
5.5.1.4 Atherectomy devices
5.5.1.5 Chronic total occlusion devices
5.5.1.6 Aortic stents
5.5.1.7 Synthetic surgical grafts
5.5.1.8 Embolic protection devices
5.5.1.9 Inferior vena cava filters
5.6 RoW
5.6.1 RoW Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
5.6.1.1 Peripheral vascular stents
5.6.1.2 Peripheral transluminal angioplasty balloon catheters
5.6.1.3 PTA guidewires
5.6.1.4 Atherectomy devices
5.6.1.5 Chronic total occlusion devices
5.6.1.6 Aortic stents
5.6.1.7 Synthetic surgical grafts
5.6.1.8 Embolic protection devices
5.6.1.9 Inferior vena cava filters

Chapter 6 Competitive Landscape
6.1 Market Share Analysis, by Key Players (%)

Chapter 7 Recommendations
7.1 Research and development initiatives
7.2 Investing in emerging economies
7.3 Mergers and acquisitions to expand the market presence

Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product portfolio
8.1.4 Business Strategies
8.1.5 Recent developments
8.2 Angioscore Inc.
8.2.1 Company overview
8.2.2 Financial overview
8.2.3 Product portfolio
8.2.4 Business strategies
8.2.5 Recent developments
8.3 Boston Scientific Corporation
8.3.1 Company overview
8.3.2 Financial overview
8.3.3 Product portfolio
8.3.4 Business strategies
8.3.5 Recent developments
8.4 C.R.Bard, Inc.
8.4.1 Company overview
8.4.2 Financial overview
8.4.3 Product portfolio
8.4.4 Business strategies
8.5 Cook Group Inc.
8.5.1 Company overview
8.5.2 Financial overview
8.5.3 Product portfolio
8.5.4 Business strategies
8.5.5 Recent developments
8.6 Cordis Corporation
8.6.1 Company overview
8.6.2 Financial overview
8.6.3 Product portfolio
8.6.4 Business strategies
8.6.5 Recent developments
8.7 Covidien PLC
8.7.1 Company overview
8.7.2 Financial overview
8.7.3 Product portfolio
8.7.4 Business strategies
8.7.5 Recent developments
8.8 Edward Lifesciences Corporation
8.8.1 Company overview
8.8.2 Financial overview
8.8.3 Product portfolio
8.8.4 Business strategies
8.8.5 Recent developments
8.9 Medtronic Inc.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 St. Jude Medical
8.10.1 Company overview
8.10.2 Financial overview
8.10.3 Product portfolio
8.10.4 Business strategies
8.10.5 Recent developments
8.11 Volcano Corporation
8.11.1 Company overview
8.11.2 Financial overview
8.11.3 Product portfolio
8.11.4 Business strategies
8.11.5 Recent developments

List of Figures

FIG. 1 Global Peripheral Vascular Devices Market, by Product Types, 2011 (USD Million)
FIG. 2 Peripheral Vascular Devices: Market Segmentation
FIG. 3 Porter's Five Forces Analysis: Global Peripheral Vascular Devices Market
FIG. 4 Market Attractiveness Analysis: Global Peripheral Vascular Devices Market, by Geography
FIG. 5 Global Peripheral Transluminal Angioplasty Balloon Catheters Market, 2010 – 2018 (USD Million)
FIG. 6 Global PTA Guidewires Market, 2010 – 2018 (USD Million)
FIG. 7 Global Chronic Total Occlusion Devices Market, 2010 – 2018 (USD Million)
FIG. 8 Global Aortic Stents Market, 2010 – 2018 (USD Million)
FIG. 9 Global Synthetic Surgical Grafts Market, 2010 – 2018 (USD Million)
FIG. 10 Comparative Analysis: Peripheral Vascular Devices Market, by Geography, 2011 & 2018 (Value %)
FIG. 11 Peripheral Vascular Devices: Market Share, by Key Players, 2012 (%)
FIG. 13 Net Sales: Boston Scientific Corporation, 2010 – 2012 (USD Billion)
FIG. 14 Net Sales: C.R.Bard, Inc., 2010 – 2012 (USD Billion)
FIG. 15 Net Sales: Covidien Plc, 2010 – 2012 (USD Billion)
FIG. 16 Net Sales: Edward Lifesciences Corporation, 2010 – 2012 (USD Billion)
FIG. 17 Net Sales: Medtronic Inc., 2010 – 2012 (USD Billion)
FIG. 18 Net Sales: St. Jude Medical, Inc., 2010 – 2012 (USD Billion)
FIG. 19 Net Sales: Volcano Corporation, 2010 – 2012 (USD Million)

List of Figures

TABLE 1 Market Snapshot: Global Peripheral Vascular Devices Market (2011 & 2018)
TABLE 2 Impact Analysis of Market Drivers
TABLE 3 Impact Analysis of Market Restraints
TABLE 4 Global Peripheral Vascular Devices Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 5 Global Peripheral Vascular Stents Market, by Segments, 2010 – 2018 (USD Million)
TABLE 6 Global Atherectomy Devices Market, by Segments, 2010 – 2018 (USD Million)
TABLE 7 Global Embolic Protection Devices Market, by Segments, 2010 – 2018 (USD Million)
TABLE 8 Global Inferior Vena Cava Filters Market, by Segments, 2010 – 2018 (USD Million)
TABLE 9 Global Peripheral Vascular Devices Market, by Geography, 2010 – 2018 (USD Million)
TABLE 10 North America Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
TABLE 11 Europe Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
TABLE 12 Asia-Pacific Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)
TABLE 13 RoW Peripheral Vascular Devices Market, by Segments, 2010 – 2018 (USD Million)

To order this report:
: Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, Size, S

__________________________

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

 


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
2. Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
3. European Market for Peripheral Vascular Devices
4. European Markets for Peripheral Vascular Devices 2012
5. North America Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others
6. Brazil Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others
7. Global Peripheral Vascular Devices Market 2011-2015
8. Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
9. Anesthesia Equipment and Associated Peripherals: Advanced, Patient-Friendly Devices Will Sustain Market Growth in Europe, States Frost & Sullivan
10. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
11. Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... BURLINGAME, Calif. , Feb. 11, 2016  NOIT™ ... announced a special "Gift of Change" campaign to assist ... units. For every such unit sold between February 10, ... a unit to a needy family. The NOIT is ... helping non/limited-verbal autistic individuals develop language skills. ...
(Date:2/11/2016)... Ore. , Feb. 11, 2016 Wellpartner, ... announce the acquisition of SolutionsRx, a full-service 340B company ... Along with providing traditional contract pharmacy services, SolutionsRx also ... clients in navigating the complex 340B regulatory environment. ... --> James R. Love , CEO of ...
(Date:2/11/2016)... Transformational M&A achieved through NPS and Dyax acquisitions ... Transformational M&A achieved through NPS and Dyax acquisitions and the ... M&A achieved through NPS and Dyax acquisitions and the announced ... with most robust pipeline in Shire , s ... most robust pipeline in Shire , s history ...
Breaking Medicine Technology:
(Date:2/11/2016)... , ... February 11, 2016 , ... ... dermatology and women’s health, is pleased to announce the promotions of Allison Kelly ... sales team, Steve Catone to executive vice president of North American capital sales, ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... unparalleled clinical decision support technology, with highly adaptable algorithms, has been updated to ... patient has signs and symptoms consistent with Zikas and a travel history to ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... J.R. Garrett Esq. as General Counsel. Garrett will focus on contract negotiations, corporate ... audits, privacy and security law, and best practices in data breaches for the ...
(Date:2/11/2016)... ... ... Colorado spine surgeon, Donald Corenman, MD, DC has been selected ... 2016 . The list consists of spine surgeons across the country nominated by their ... the importance of clinical excellence; he has been awarded the Patient’s Choice Award, Compassionate ...
(Date:2/11/2016)... ... February 11, 2016 , ... Duterte Insurance ... involvement program, introduces a new charity campaign to raise funds for Ronald McDonald ... accepted at https://donate.rmhc.org/ . , Ronald McDonald House (RMH) is an internationally ...
Breaking Medicine News(10 mins):